Compile Data Set for Download or QSAR
Report error Found 322 Enz. Inhib. hit(s) with Target = 'Probable global transcription activator SNF2L2'
TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50658511BDBM50658511(CHEMBL6152639)
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/5/2026
Entry Details PubMed
TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50539801BDBM50539801(CHEMBL4648912 | US11840533, Compound 70)
Affinity DataKd: <1nMAssay Description:Binding affinity to human partial length SMARCA2 (S1377 to Q1486 residues) expressed in bacterial expression system by BROMOscan assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2021
Entry Details Article
PubMed
TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50642737BDBM50642737(CHEMBL5564941)
Affinity DataIC50: 1.20nMAssay Description:Binding affinity to his-tagged BRM bromodomain (unknown origin) by alpha-LISA assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/12/2025
Entry Details
PubMed
TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50661194BDBM50661194(CHEMBL6162306)
Affinity DataIC50: 1.60nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/5/2026
Entry Details PubMed
TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 394434BDBM394434(US10308614, Example 35 | 2-(6-amino-5-(pyrrolidin-)
Affinity DataKd:  2nMAssay Description:Binding affinity to SMARCA2 (unknown origin) assessed as dissociation constant by BROMOscan LeadHunter assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/19/2024
Entry Details
PubMed
TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50661198BDBM50661198(CHEMBL6163796)
Affinity DataIC50: 2.30nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/5/2026
Entry Details PubMed
TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50642738BDBM50642738(CHEMBL5571722)
Affinity DataIC50: 2.70nMAssay Description:Binding affinity to his-tagged BRM bromodomain (unknown origin) by alpha-LISA assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/12/2025
Entry Details
PubMed
TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50658055BDBM50658055(CHEMBL6162599)
Affinity DataIC50: 2.80nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sidPDB
In Depth
Date in BDB:
6/5/2026
Entry Details PubMedPDB3D3D Structure (crystal)
TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50658488BDBM50658488(CHEMBL6133855)
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/5/2026
Entry Details PubMed
TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50628856BDBM50628856(CHEMBL5412292)
Affinity DataKd:  3nMAssay Description:Binding affinity to SMARCA2 (unknown origin) assessed as dissociation constant by BROMOscan LeadHunter assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/19/2024
Entry Details
PubMed
TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50658511BDBM50658511(CHEMBL6152639)
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/5/2026
Entry Details PubMed
TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50661196BDBM50661196(CHEMBL6160404)
Affinity DataIC50: 3.60nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/5/2026
Entry Details PubMed
TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50658486BDBM50658486(CHEMBL6145659)
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/5/2026
Entry Details PubMed
TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50658485BDBM50658485(CHEMBL6164767)
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/5/2026
Entry Details PubMed
TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50658484BDBM50658484(CHEMBL6166760)
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/5/2026
Entry Details PubMed
TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50658049BDBM50658049(CHEMBL6162246)
Affinity DataIC50: 4.60nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/5/2026
Entry Details PubMed
LigandChemical structure of BindingDB Monomer ID 50469331BDBM50469331(CHEMBL4282980 | US11958846, Example 6)
Affinity DataIC50: 5nMAssay Description:All subsequent reagent additions were performed using a MultiFlo FX Multi-Mode Dispenser. Assay buffer was 20 mM HEPES pH 7.5, 1 mM MgCl2, 20 mM KCl,...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2024
Entry Details
US Patent

LigandChemical structure of BindingDB Monomer ID 50469330BDBM50469330(CHEMBL4295096 | US11958846, Example 7)
Affinity DataIC50: 5nMAssay Description:All subsequent reagent additions were performed using a MultiFlo FX Multi-Mode Dispenser. Assay buffer was 20 mM HEPES pH 7.5, 1 mM MgCl2, 20 mM KCl,...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2024
Entry Details
US Patent

LigandChemical structure of BindingDB Monomer ID 50469324BDBM50469324(CHEMBL4286345 | US11958846, Example 4)
Affinity DataIC50: 5nMAssay Description:All subsequent reagent additions were performed using a MultiFlo FX Multi-Mode Dispenser. Assay buffer was 20 mM HEPES pH 7.5, 1 mM MgCl2, 20 mM KCl,...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2024
Entry Details
US Patent

TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50469330BDBM50469330(CHEMBL4295096 | US11958846, Example 7)
Affinity DataIC50: 5nMAssay Description:Inhibition of recombinant His10-tagged ZZ-HCV3C-BRM ATPase-SnAC (636 to 1331 residues) (unknown origin) expressed in insect sf9 cells preincubated fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2020
Entry Details Article
PubMed
LigandChemical structure of BindingDB Monomer ID 50469320BDBM50469320(CHEMBL4293567 | US11958846, Example 5)
Affinity DataIC50: 5nMAssay Description:All subsequent reagent additions were performed using a MultiFlo FX Multi-Mode Dispenser. Assay buffer was 20 mM HEPES pH 7.5, 1 mM MgCl2, 20 mM KCl,...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2024
Entry Details
US Patent

TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50469329BDBM50469329(CHEMBL4278436 | US11958846, Example 1)
Affinity DataIC50: 5nMAssay Description:Inhibition of recombinant His10-tagged ZZ-HCV3C-BRM ATPase-SnAC (636 to 1331 residues) (unknown origin) expressed in insect sf9 cells preincubated fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2020
Entry Details Article
PubMed
TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50469331BDBM50469331(CHEMBL4282980 | US11958846, Example 6)
Affinity DataIC50: 5nMAssay Description:Inhibition of recombinant His10-tagged ZZ-HCV3C-BRM ATPase-SnAC (636 to 1331 residues) (unknown origin) expressed in insect sf9 cells preincubated fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2020
Entry Details Article
PubMed
TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50658478BDBM50658478(Camibirstat | Fhd-286)
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/5/2026
Entry Details PubMed
TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50658510BDBM50658510(CHEMBL6141585)
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/5/2026
Entry Details PubMed
TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50658478BDBM50658478(Camibirstat | Fhd-286)
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/5/2026
Entry Details PubMed
TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50469320BDBM50469320(CHEMBL4293567 | US11958846, Example 5)
Affinity DataIC50: 5nMAssay Description:Inhibition of recombinant His10-tagged ZZ-HCV3C-BRM ATPase-SnAC (636 to 1331 residues) (unknown origin) expressed in insect sf9 cells preincubated fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2020
Entry Details Article
PubMed
TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50658516BDBM50658516(CHEMBL6162637)
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/5/2026
Entry Details PubMed
TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50469324BDBM50469324(CHEMBL4286345 | US11958846, Example 4)
Affinity DataIC50: 5nMAssay Description:Inhibition of recombinant His10-tagged ZZ-HCV3C-BRM ATPase-SnAC (636 to 1331 residues) (unknown origin) expressed in insect sf9 cells preincubated fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2020
Entry Details Article
PubMed
TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50469330BDBM50469330(CHEMBL4295096 | US11958846, Example 7)
In Depth
Date in BDB:
6/6/2026
Entry Details PubMed
LigandChemical structure of BindingDB Monomer ID 50469329BDBM50469329(CHEMBL4278436 | US11958846, Example 1)
Affinity DataIC50: 5nMAssay Description:All subsequent reagent additions were performed using a MultiFlo FX Multi-Mode Dispenser. Assay buffer was 20 mM HEPES pH 7.5, 1 mM MgCl2, 20 mM KCl,...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2024
Entry Details
US Patent

TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50658504BDBM50658504(CHEMBL6162908)
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/5/2026
Entry Details PubMed
TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50658520BDBM50658520(CHEMBL6167580)
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/5/2026
Entry Details PubMed
TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50658517BDBM50658517(CHEMBL6144331)
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/5/2026
Entry Details PubMed
TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50658520BDBM50658520(CHEMBL6167580)
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/5/2026
Entry Details PubMed
TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50661199BDBM50661199(CHEMBL6134086)
Affinity DataIC50: 6.30nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/5/2026
Entry Details PubMed
TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50661195BDBM50661195(CHEMBL6165182)
Affinity DataIC50: 6.70nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/5/2026
Entry Details PubMed
TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50658510BDBM50658510(CHEMBL6141585)
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/5/2026
Entry Details PubMed
TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50658526BDBM50658526(CHEMBL6133150)
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/5/2026
Entry Details PubMed
TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50658523BDBM50658523(CHEMBL6143779)
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/5/2026
Entry Details PubMed
TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50658517BDBM50658517(CHEMBL6144331)
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/5/2026
Entry Details PubMed
TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50661197BDBM50661197(CHEMBL6168928)
Affinity DataIC50: 8.10nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/5/2026
Entry Details PubMed
TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50658050BDBM50658050(CHEMBL6102929)
Affinity DataIC50: 8.80nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sidPDB
In Depth
Date in BDB:
6/5/2026
Entry Details PubMedPDB3D3D Structure (crystal)
TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50664993BDBM50664993(CHEMBL6174634)
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/6/2026
Entry Details PubMed
TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50658526BDBM50658526(CHEMBL6133150)
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/5/2026
Entry Details PubMed
TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50658500BDBM50658500(CHEMBL6150430)
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/5/2026
Entry Details PubMed
TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50664992BDBM50664992(CHEMBL6175093)
Affinity DataIC50: 9.10nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/6/2026
Entry Details PubMed
TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50664990BDBM50664990(CHEMBL1616543)
Affinity DataIC50: 9.20nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/6/2026
Entry Details PubMed
TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 394584BDBM394584(US10308614, Example 187 | 2-(6-amino-5-(1-methyl-)
Affinity DataKd:  10nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/6/2026
Entry Details PubMed
TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 394584BDBM394584(US10308614, Example 187 | 2-(6-amino-5-(1-methyl-)
Affinity DataKd:  10nMAssay Description:Binding affinity to SMARCA2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2024
Entry Details
PubMed
Displayed 1 to 50 (of 322 total ) | Next | Last >>
Jump to: